The use of strontium 89 forpalliation of pain from bone metastases associated with hormone-refractory prostate cancer

This publication has 12 references indexed in Scilit:

• Cancer statistics, 1994
  CA: A Cancer Journal for Clinicians, 1994
• Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1993
• Strontium-89 chloride for pain palliation in prostatic skeletal malignancy
  The British Journal of Radiology, 1991
• A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
  European Journal of Cancer and Clinical Oncology, 1991
• Bone metastases: pathophysiology and management policy.
  Journal of Clinical Oncology, 1991
• Phase III studies to compare goserelin (zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma
  Urology, 1989
• Strontium-89: treatment results and kinetics in patients with painful metastatic prostate and breast cancer in bone.
  RadioGraphics, 1989
• Treatment of metastatic bone pain with strontium-89
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1987
• Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate
  European Journal of Nuclear Medicine and Molecular Imaging, 1986
• Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer
  New England Journal of Medicine, 1984